| # | Drug | Count |
|---|---|---|
| 0 | BUPRENORPHINE | 9 |
| 1 | BUPIVACAINE | 5 |
| 2 | BUPIVACAINE HYDROCHLORIDE IN DEXTROSE | 5 |
| 3 | METHADONE | 5 |
| 4 | CLONIDINE | 4 |
| 5 | FENTANYL | 4 |
| 6 | GABAPENTIN | 4 |
| 7 | MORPHINE | 4 |
| 8 | LAMIVUDINE | 3 |
| 9 | LAMIVUDINE ORAL | 3 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | COCAINE HYDROCHLORIDE | 1 | 0.0026 |
| 1 | BUPIVACAINE HYDROCHLORIDE IN DEXTROSE | 5 | 0.0007 |
| 2 | BUPIVACAINE | 5 | 0.0005 |
| 3 | PROPYLTHIOURACIL | 1 | 0.0005 |
| 4 | NELFINAVIR MESYLATE | 1 | 0.0005 |
| 5 | SODIUM FERRIC GLUCONATE COMPLEX | 1 | 0.0005 |
| 6 | ZIDOVUDINE | 3 | 0.0003 |
| 7 | CENOBAMATE | 2 | 0.0002 |
| 8 | ZONISAMIDE | 2 | 0.0002 |
| 9 | RITONAVIR 100 MG | 2 | 0.0001 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Thyroid Hormone Synthesis Inhibitor [EPC] | 1 | 0.0001 |
| 1 | Partial Opioid Agonist [EPC] | 9 | 0.0001 |
| 2 | Human Immunodeficiency Virus 1 Non-Nucleoside Analog Reverse Transcriptase Inhibitor [EPC] | 2 | 0.0001 |
| 3 | Central alpha-2 Adrenergic Agonist [EPC] | 4 | 0.0001 |
| 4 | Parenteral Iron Replacement [EPC] | 1 | 0.0001 |
| 5 | Protease Inhibitor [EPC] | 3 | 0.0001 |
| 6 | Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC] | 3 | 0.0001 |
| 7 | Amide Local Anesthetic [EPC] | 5 | 0.0001 |
| 8 | Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC] | 6 | 0.0001 |
| 9 | Cytochrome P450 3A Inhibitor [EPC] | 3 | 0.0000 |